Literature DB >> 11162352

Lysyl oxidases: expression in the fetal membranes and placenta.

S Hein1, S Y Yamamoto, K Okazaki, C Jourdan-LeSaux, K Csiszar, G D Bryant-Greenwood.   

Abstract

The cross-linking of the connective tissues in the fetal membranes and placenta is important for their tensile strength and elasticity. We have studied the expression of lysyl oxidase (LOX) because it is the classical enzyme responsible for the cross-linking of collagen and elastin. We have also studied the two recently described, genetically distinct lysyl oxidase-like genes and proteins, lysyl oxidase-like (LOXL) and lysyl oxidase-like 2 (LOXL2), of unknown functions. Specific antisera have been used for immunolocalization in fetal membranes and placentae from early pregnancy terminations and after caesarean section at both preterm and term, prior to labour. In addition, the steady state mRNA levels of the three genes has been quantitated in separated amnion, chorion, decidua and placentae collected at term before labour. The immunocytochemistry shows that the spatial expression of the three lysyl oxidases is similar in early pregnancy in both the fetal membranes and placentae. However, by preterm this pattern had diverged and becomes greatest at term. The expression of the genes found at term was similar to the results of protein expression obtained by immunocytochemistry, with the exception of LOXL which had high placental gene expression, but low levels of immunolocalized protein. Thus by term, LOX was expressed predominantly in the amniotic epithelium, with little expression in the placenta, while LOXL showed highest gene expression in the placenta and lowest expression in the amnion. LOXL2 expression was again different and was expressed predominantly in the chorionic cytotrophoblast of the membranes with low expression in both the amnion and placentae. These results suggest that these three members of the lysyl oxidase family may have similar roles in early pregnancy during the development of the placenta and fetal membranes, but their divergence as pregnancy advances to term, may reflect changes in substrate specificity and connective tissue composition. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162352     DOI: 10.1053/plac.2000.0580

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  10 in total

1.  Role of NF-κB/GATA3 in the inhibition of lysyl oxidase by IL-1β in human amnion fibroblasts.

Authors:  Chuyue Zhang; Wangsheng Wang; Chao Liu; Jiangwen Lu; Kang Sun
Journal:  Immunol Cell Biol       Date:  2017-10-03       Impact factor: 5.126

2.  A single nucleotide polymorphism in the promoter of the LOXL1 gene and its relationship to pelvic organ prolapse and preterm premature rupture of membranes.

Authors:  Georgia Ferrell; Minyan Lu; Paul Stoddard; Mary D Sammel; Roberto Romero; Jerome F Strauss; Catherine A Matthews
Journal:  Reprod Sci       Date:  2009-01-30       Impact factor: 3.060

3.  Down-regulation of the transcription factor snail in the placentas of patients with preeclampsia and in a rat model of preeclampsia.

Authors:  Larisa Fedorova; Cara Gatto-Weis; Sleiman Smaili; Nauman Khurshid; Joseph I Shapiro; Deepak Malhotra; Terrence Horrigan
Journal:  Reprod Biol Endocrinol       Date:  2012-02-23       Impact factor: 5.211

4.  Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.

Authors:  Vineeth S Rajkumar; Kevin Howell; Katalin Csiszar; Christopher P Denton; Carol M Black; David J Abraham
Journal:  Arthritis Res Ther       Date:  2005-07-21       Impact factor: 5.156

5.  Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans.

Authors:  Xiang-Hong Xu; Xue-Wen Huang; Li Qun; Ya-Nan Li; Yi Wang; Chao Liu; Yanyun Ma; Qing-Mei Liu; Kang Sun; Feng Qian; Li Jin; Jiucun Wang
Journal:  Sci Rep       Date:  2014-12-12       Impact factor: 4.379

6.  An increase in elastogenic components in the placental villi of women with chronic venous disease during pregnancy is associated with decreased EGFL7 expression level.

Authors:  Miguel A Ortega; Ángel Asúnsolo; Oscar Fraile-Martínez; Felipe Sainz; Miguel A Saez; Coral Bravo; Juan A De León-Luis; Miguel A Alvarez-Mon; Santiago Coca; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

Review 7.  Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy.

Authors:  Henry C Ezechukwu; Cornelius A Diya; Ifunanya J Egoh; Mayowa J Abiodun; John-Ugwuanya A Grace; God'spower R Okoh; Kayode T Adu; Oyelola A Adegboye
Journal:  Ther Adv Infect Dis       Date:  2021-07-22

8.  Analysis of the transcriptome of bovine endometrial cells isolated by laser micro-dissection (1): specific signatures of stromal, glandular and luminal epithelial cells.

Authors:  Wiruntita Chankeaw; Sandra Lignier; Christophe Richard; Theodoros Ntallaris; Mariam Raliou; Yongzhi Guo; Damien Plassard; Claudia Bevilacqua; Olivier Sandra; Göran Andersson; Patrice Humblot; Gilles Charpigny
Journal:  BMC Genomics       Date:  2021-06-18       Impact factor: 3.969

9.  Transcriptome analysis of PPARγ target genes reveals the involvement of lysyl oxidase in human placental cytotrophoblast invasion.

Authors:  Nadine Segond; Séverine A Degrelle; Sarah Berndt; Elodie Clouqueur; Christine Rouault; Bruno Saubamea; Philippe Dessen; Keith S K Fong; Katalin Csiszar; Josette Badet; Danièle Evain-Brion; Thierry Fournier
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

10.  Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions - An in-silico study.

Authors:  Ashikh A Seethy; Sunil Singh; Indrani Mukherjee; Karthikeyan Pethusamy; Kakali Purkayastha; Jai Bhagwan Sharma; Radhey S Sharma; Ruby Dhar; Subhradip Karmakar
Journal:  Placenta       Date:  2020-10-22       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.